Evidence map›Paper›PMID 26738561›Full record

ArticleScientific reports2016

Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape.

Thomas Peacock, Kolli Reddy, Joe James, Beata Adamiak, Wendy Barclay, Holly Shelton, Munir Iqbal

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Egyptian rousette bat humoral immunity to H9 influenza hemagglutinin.bioRxiv : the preprint server for biology · 2026
    Article
  3. Genetic diversity of H9N2 avian influenza viruses in Iran over the past two decades.Veterinary research forum : an international quarterly journal · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas PeacockThe Pirbright Institute, Pirbright, Woking, UK.
Kolli ReddyThe Pirbright Institute, Pirbright, Woking, UK.
Joe JamesThe Pirbright Institute, Pirbright, Woking, UK.
Beata AdamiakThe Pirbright Institute, Pirbright, Woking, UK.
Wendy BarclayImperial College London, UK.
Holly SheltonThe Pirbright Institute, Pirbright, Woking, UK.
Munir IqbalThe Pirbright Institute, Pirbright, Woking, UK.
The Pirbright Institute · GBImperial College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L018853/1Biotechnology and Biological Sciences Research Council BBS/E/00001759Biotechnology and Biological Sciences Research Council BBS/E/I/00001708British Heart Foundation
6 · The paper itself

Abstract

H9N2 avian influenza virus is a major cause of poultry production loss across Asia leading to the wide use of vaccines. Efficacy of vaccines is often compromised due to the rapid emergence of antigenic variants. To improve the effectiveness of vaccines in the field, a better understanding of the antigenic epitopes of the major antigen, hemagglutinin, is required. To address this, a panel of nine monoclonal antibodies were generated against a contemporary Pakistani H9N2 isolate, which represents a major Asian H9N2 viral lineage. Antibodies were characterized in detail and used to select a total of 26 unique 'escape' mutants with substitutions across nine different amino acid residues in hemagglutinin including seven that have not been described as antigenic determinants for H9N2 viruses before. Competition assays and structural mapping revealed two novel, discrete antigenic sites "H9-A" and "H9-B". Additionally, a second subset of escape mutants contained amino acid deletions within the hemagglutinin receptor binding site. This constitutes a novel method of escape for group 1 hemagglutinins and could represent an alternative means for H9N2 viruses to overcome vaccine induced immunity. These results will guide surveillance efforts for arising antigenic variants as well as evidence based vaccine seed selection and vaccine design.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnimalsAntibodies, Monoclonal, Murine-DerivedAntibodies, NeutralizingAntibodies, ViralAntigens, ViralChickensCross ReactionsEpitope MappingHumansHybridomasImmune EvasionImmune SeraInfluenza A Virus, H9N2 SubtypeInfluenza, HumanAntibodies, Monoclonal, Murine-DerivedAntibodies, NeutralizingAntibodies, ViralAntigens, ViralImmune SeraIntracellular Signaling Peptides and ProteinsWDFY2 protein, human

Identifiers

PMID26738561
PMCPMC4704030
OpenAlexW2230777275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.